Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.

We Liked it at $3.50, we Love it at $2.25. Down but not out. Now trading below the cash they have in the bank, this...

Revive Therapeutics (RVVTF) Advancing MDMA Thermal Patch.

Two News Reports Related to Revives Upcoming Microneedle Patch Technology While we are still laser focused on Revive having a successful meeting with the FDA...
Silo Pharma, Psychedelic Stock Review, Roland Rick Perry

SILO Pharma (SILO) Gains 53%

For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun. Silo Pharma Gains 53% Intraday on Patent (Ketamine) Related News Our opinion...

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion) and there...

Adding ATAI (ATAI) to 2024 Watch List. Doubling Down at $1.80, After Anti Depression...

Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm. Atai was founded in 2018 and went public in June...

Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!

And We Weren't Watching! It was Friday after all, and the last day of the year, and we were celebrating our 78% gain in Ardelyx...
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE...

Adding Silo Pharma (SILO) $3.50 to Watch List.

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude. We...

Revive Therapeutics (RVVTF) Enters the Danger Zone.

What Danger You Ask? Danger #1, the FDA doesn't like the data, and you own the stock. Danger #2, the FDA does like the data, and...
ehave

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its...

Latest article

GeoVax (GOVX) Surges 51% on Massive Volume Spike.

MonkeyPox and Gedeptin Related News Spark New Investor Interest. MARKET BRIEF On a quiet Thursday afternoon, the 30th, while we were nearing completion of an updated...

Paving Past Obstacles on the Path to US Biosecurity

GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China. National biosecurity has become a frequent topic of conversation in...

Dinner Presentation With BioStem Technologies, Inc. (BSEM) in Boca Raton, FL

LIVE QUOTE LONGER TERM CHART Contact Ray Oliver at Bear Creek Capital for details. RECENT NEWS PRESENTATION https://youtu.be/Au-pIqDHyto?si=_JKFAhwT-vvLSFqe WOUND CARE REPORT Global Wound Care Market to Reach USD 30.48 Billion by...